Targeting a molecule involved in the activation and movement of white blood cells could prevent the progression of multiple sclerosis (MS), University of Adelaide researchers have found.
Please login below to view content or subscribe now.
Targeting a molecule involved in the activation and movement of white blood cells could prevent the progression of multiple sclerosis (MS), University of Adelaide researchers have found.
Please login below to view content or subscribe now.
To continue onto Campus Review, please select your institution.